🎉 M&A multiples are live!
Check it out!

Aplisens Valuation Multiples

Discover revenue and EBITDA valuation multiples for Aplisens and similar public comparables like Q-Interline, NanoFocus, and Optiscan Imaging.

Aplisens Overview

About Aplisens

Aplisens SA is engaged in manufacturing of measuring instruments. It focuses on electronic pressure and differential pressure measurement technology. The company's products include differential pressure transmitters, hydrostatic level probes, level transmitters, valves, digital indicators and power supplies.


Founded

1992

HQ

Poland
Employees

489

Website

aplisens.pl

Financials

LTM Revenue $44.6M

LTM EBITDA $10.4M

EV

$53.3M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 12K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Aplisens Financials

Aplisens has a last 12-month revenue (LTM) of $44.6M and a last 12-month EBITDA of $10.4M.

In the most recent fiscal year, Aplisens achieved revenue of $43.2M and an EBITDA of $9.8M.

Aplisens expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Aplisens valuation multiples based on analyst estimates

Aplisens P&L

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue $44.6M XXX $43.2M XXX XXX XXX
Gross Profit n/a XXX $15.9M XXX XXX XXX
Gross Margin n/a XXX 37% XXX XXX XXX
EBITDA $10.4M XXX $9.8M XXX XXX XXX
EBITDA Margin 23% XXX 23% XXX XXX XXX
EBIT $7.9M XXX $7.3M XXX XXX XXX
EBIT Margin 18% XXX 17% XXX XXX XXX
Net Profit $6.2M XXX $5.8M XXX XXX XXX
Net Margin 14% XXX 13% XXX XXX XXX
Net Debt XXX XXX n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Aplisens Stock Performance

As of July 17, 2025, Aplisens's stock price is PLN 19 (or $5).

Aplisens has current market cap of PLN 215M (or $59.7M), and EV of PLN 192M (or $53.3M).

See Aplisens trading valuation data

Aplisens Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$53.3M $59.7M XXX XXX XXX XXX $0.52

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Aplisens Valuation Multiples

As of July 17, 2025, Aplisens has market cap of $59.7M and EV of $53.3M.

Aplisens's trades at 1.2x EV/Revenue multiple, and 5.4x EV/EBITDA.

Equity research analysts estimate Aplisens's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

Aplisens has a P/E ratio of 9.6x.

See valuation multiples for Aplisens and 12K+ public comps

Aplisens Financial Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Market cap (current) $59.7M XXX $59.7M XXX XXX XXX
EV (current) $53.3M XXX $53.3M XXX XXX XXX
EV/Revenue 1.2x XXX 1.2x XXX XXX XXX
EV/EBITDA 5.1x XXX 5.4x XXX XXX XXX
EV/EBIT 6.8x XXX 7.3x XXX XXX XXX
EV/Gross Profit n/a XXX n/a XXX XXX XXX
P/E 9.6x XXX 10.4x XXX XXX XXX
EV/FCF n/a XXX 16.9x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Aplisens Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Aplisens Margins & Growth Rates

Aplisens's last 12 month revenue growth is 3%

Aplisens's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $18K for the same period.

Aplisens's rule of 40 is 32% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Aplisens's rule of X is 30% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Aplisens and other 12K+ public comps

Aplisens Operational Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue Growth 3% XXX n/a XXX XXX XXX
EBITDA Margin 23% XXX 23% XXX XXX XXX
EBITDA Growth 6% XXX -9% XXX XXX XXX
Rule of 40 32% XXX 25% XXX XXX XXX
Bessemer Rule of X XXX XXX 30% XXX XXX XXX
Revenue per Employee XXX XXX $0.1M XXX XXX XXX
Opex per Employee XXX XXX $18K XXX XXX XXX
S&M Expenses to Revenue XXX XXX 5% XXX XXX XXX
G&A Expenses to Revenue XXX XXX n/a XXX XXX XXX
R&D Expenses to Revenue XXX XXX n/a XXX XXX XXX
Opex to Revenue XXX XXX 20% XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Aplisens Public Comps

See public comps and valuation multiples for Sensors & Instruments comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Catapult XXX XXX XXX XXX XXX XXX
Optiscan Imaging XXX XXX XXX XXX XXX XXX
NanoFocus XXX XXX XXX XXX XXX XXX
Q-Interline XXX XXX XXX XXX XXX XXX
Jenoptik XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Aplisens M&A and Investment Activity

Aplisens acquired  XXX companies to date.

Last acquisition by Aplisens was  XXXXXXXX, XXXXX XXXXX XXXXXX . Aplisens acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Aplisens

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Start Free Trial

About Aplisens

When was Aplisens founded? Aplisens was founded in 1992.
Where is Aplisens headquartered? Aplisens is headquartered in Poland.
How many employees does Aplisens have? As of today, Aplisens has 489 employees.
Is Aplisens publicy listed? Yes, Aplisens is a public company listed on WAR.
What is the stock symbol of Aplisens? Aplisens trades under APN ticker.
When did Aplisens go public? Aplisens went public in 2009.
Who are competitors of Aplisens? Similar companies to Aplisens include e.g. Catapult, Optiscan Imaging, NanoFocus, Q-Interline.
What is the current market cap of Aplisens? Aplisens's current market cap is $59.7M
What is the current revenue of Aplisens? Aplisens's last 12 months revenue is $44.6M.
What is the current revenue growth of Aplisens? Aplisens revenue growth (NTM/LTM) is 3%.
What is the current EV/Revenue multiple of Aplisens? Current revenue multiple of Aplisens is 1.2x.
Is Aplisens profitable? Yes, Aplisens is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Aplisens? Aplisens's last 12 months EBITDA is $10.4M.
What is Aplisens's EBITDA margin? Aplisens's last 12 months EBITDA margin is 23%.
What is the current EV/EBITDA multiple of Aplisens? Current EBITDA multiple of Aplisens is 5.1x.

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.